A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Pfizer
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Beijing Biotech
The General Hospital of Western Theater Command
Affiliated Hospital to Academy of Military Medical Sciences
Hangzhou Sumgen Biotech Co., Ltd.
ModernaTX, Inc.
Nanjing IASO Biotechnology Co., Ltd.
Genentech, Inc.
Regeneron Pharmaceuticals
Bristol-Myers Squibb
Pfizer
C4 Therapeutics, Inc.
Sumitomo Pharma America, Inc.
Celgene
Celgene
Cellectar Biosciences, Inc.
Guangzhou Bio-gene Technology Co., Ltd
Janssen Research & Development, LLC
Massachusetts General Hospital
Wake Forest University Health Sciences
Jiangsu Simcere Pharmaceutical Co., Ltd.
C4 Therapeutics, Inc.
Celgene
Qilu Pharmaceutical Co., Ltd.
University of Miami
Senti Biosciences
Gilead Sciences
Pfizer
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Institute of Hematology & Blood Diseases Hospital, China
Celgene
Memorial Sloan Kettering Cancer Center
Excyte Biopharma Ltd
O&D BioTech Group CO., Limited
GlaxoSmithKline
Massachusetts General Hospital
Assistance Publique - Hôpitaux de Paris
Massachusetts General Hospital
Massachusetts General Hospital
Shandong New Time Pharmaceutical Co., LTD
Karyopharm Therapeutics Inc
Genmab
Icahn School of Medicine at Mount Sinai